Arcellx Is Maintained at Buy by Canaccord Genuity
CCORF Maintains Arcellx(ACLX.US) With Buy Rating, Raises Target Price to $121
Redburn Initiates Arcellx at Buy With $109 Price Target
Possible Bearish Signals With Arcellx Insiders Disposing Stock
CCORF Maintains Arcellx(ACLX.US) With Buy Rating, Maintains Target Price $85
Express News | Arcellx Inc : Piper Sandler Raises Target Price to $91 From $70
Arcellx Inc's Anito-cel Shows Promising Efficacy in Treating Challenging Multiple Myeloma, Merits Buy Rating
There's Reason For Concern Over Arcellx, Inc.'s (NASDAQ:ACLX) Massive 28% Price Jump
Arcellx Insider Sold Shares Worth $1,840,053, According to a Recent SEC Filing
Cantor Fitzgerald Initiates Arcellx(ACLX.US) With Buy Rating
Cantor Fitzgerald analyst Rick Bienkowski initiates coverage on $Arcellx(ACLX.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 12.5% and a total average return of -
Cantor Fitzgerald Initiates Arcellx at Overweight
CCORF Maintains Arcellx(ACLX.US) With Buy Rating, Maintains Target Price $85
CCORF analyst John Newman maintains $Arcellx(ACLX.US)$ with a buy rating, and maintains the target price at $85.According to TipRanks data, the analyst has a success rate of 39.0% and a total
Buy Rating for Arcellx Inc: Operational Efficiencies and Market Advantages Over Legend/JnJ Propel Positive Outlook
Buy Rating Affirmed for Arcellx Inc. on Strong CAR-T Therapy Prospects and Financial Stability
Express News | Arcellx Inc : UBS Cuts Target Price to $77 From $78
Calculating The Intrinsic Value Of Arcellx, Inc. (NASDAQ:ACLX)
Arcellx Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results.
Analysts Are Bullish on These Healthcare Stocks: Royalty Pharma (RPRX), Arcellx Inc (ACLX)
Piper Sandler Issues a Buy Rating on Arcellx Inc (ACLX)
Needham Reiterates Buy on Arcellx, Maintains $81 Price Target